Orthobiologics Market

Orthobiologics Market: Viscosupplements Product Type Segment to Gain Traction by the End of the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)

  • 2017-11-16
  • REP-GB-786
  • 282 pages
  • Format: PDF/PPT/Excel

An Incisive, In-depth Analysis on the Orthobiologics Market

This study offers a comprehensive, 360 degree analysis on the Orthobiologics market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Orthobiologics market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

According to the research report published by Future Market Insights, the global orthobiologics market is expected grow at a slow rate during the assessment period 2017-2027. However, it did not reflect slack or negative growth since past years and is likely to show a slow yet an upward rise in the coming years. The revenue generated by global orthobiologics market in 2017 reached US$ 4869 Mn and by the end of the assessment year, it is estimated to reach a value less than US$ 7 Bn. The research study portrays several opportunities in the global orthobiologics market. As mentioned in this study, the rising geriatric population can be considered as a beneficial prospect. Increasing geriatric population offers surplus opportunities for the manufactures of orthobiologics. The major root of amputations are diseases related to ageing as osteoarthritis, musculoskeletal diseases, spine deformity, etc. Increase incidence of accidents owing to increasing urbanization is also a major factor expected to create numerous opportunities for orthobiologics manufacturers. Elevating surgical procedures also presents growth opportunities for the market. The increased incidences of trauma cases, lifestyle related diseases and other chronic disorders have led to rise in number of orthopaedic surgeries at a global level. This growing trend is anticipated to increase the sales of orthobiologics products in present and forthcoming years.

Emergence of online sales channel and government initiatives bot are contributing to the growth of the market. Manufacturers are focussed on creating sales directly through their company’s website to target more customers and without the interference of third-party distributors. This enables the manufacturers to eliminate the variation in product pricing owing to the involvement of third-party suppliers.

Bone graft substitutes continue to exert a hold on the global market

Bone graft substitute segment in the product type category is expected to dominate the global market in the years to follow. This segment was a lucrative one since 2012. During the 2012-2016 timeline, bone graft substitute segment reflected high growth opportunities and led the global market. This trend is observed in the current market scenario and is expected to continue over the period of assessment. In 2017, bone graft substitute segment registered a value of US$ US$ 2521.6 Mn and is according to the growth trend exhibited by this segment, it is estimated to reach a market valuation of above US$ 3 Bn by the end of 2027. During the forecast period of 2017-2027, it is poised to reflect a CAGR of 3.0%.

Xenografts to show high potential for growth adding to the domination of bone graft substitutes

Bone graft substitute segment is further analysed and divided into allograft, xenograft, synthetic and bone morphogenetic protein sub segments. Of these, xenograft sub segment is expected to run at the highest pace to register a meteoric CAGR of 10.0% throughout the period of forecast. This segment is the second largest in terms of market value. Allograft and synthetic sub segments have a large yet almost equal contribution to the revenue of the parent segment. The allograft sub segment is estimated to reach a valuation of US$ 937.5 Mn leading other sub segments. However, the synthetic sub category is poised to grow at a relatively higher rate than allografts in the coming years.

Weighted analysis to achieve strategic proficiency

The market research study on orthobiologics market drafted by Future Market Insights is an extensive research publication that covers the global scenario of orthobiologics market. It includes various macroeconomic factors, opportunity assessment, key growth drivers, restraints and vital segmental analysis. The quantification of data pertaining to these aspects with the help of statistical representations and analysis giving a holistic and an unbiased view of the entire market. The research publication assists the reader in judging the future prospects in orthobiologics across key regions in the globe. Every market segment is assessed in different regions giving a heads up to the reader and assisting in determining revenue pockets for the growth of his/her business. The statistical analysis and forecasting helps in getting a clear market understanding and its scenario in the future based on market acumen of current market standing and historical data. Data mining and number crunching is done with extreme precision to cover analysis of the entire ecosystem of the orthobiologics market. All these insights and qualitative and quantitative analysis of the market is presented in a systematic format in the research report titled “Orthobiologics Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”.

Market Segmentation

The global orthobiologics market is segmented in detail so as to cover every aspect of the market and present a complete market intelligence in front of the reader.

By Product Type

By End User

By Region

  • Bone Growth Stimulators (BGS)

    • Non-Invasive Electrical BGS

    • Invasive Electrical BGS

    • Ultrasound BGS

  • Viscosupplements

    • Single Injection Viscosupplements

    • Three Injection Viscosupplements

    • Five Injection Viscosupplements

  • Bone Graft Substitute

    • Allografts

    • Synthetics

    • Xenografts

    • Bone Morphogenetic Protein

  • Hospitals

  • Ambulatory Surgical Centres

  • Orthopaedics Clinics

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Asia Pacific excluding Japan (APEJ)

  • Japan

  • Middle East and Africa (MEA)

Assumptions used in this research report

While drafting this extensive research report, we have considered market consolidation activities such as merger and acquisition, collaborations, partnerships, which may influence the market growth over a forecast period. Capital expenditure on healthcare infrastructure in the developing economies is also a factor, expected to drives the market. It also rules out impact of extreme events in specific countries. Regulatory impositions such as the rules and regulations by the various regulatory authorities such as U.S. Food and Drug Administration and European Commission could affect the market. Currency fluctuations and changing taxation policies would have a significant impact on forecasting of orthobiologics over the forecast period.

Reasons supporting your investment in this research report

This research study gives a near to 100 percent accurate results pertaining to every segment globally as well as regionally, during the current year as well as 10 years down the line (2017-2027). To ensure data and statistical accuracy, an effective research methodology has been followed that covers extensive secondary research to acquire relevant market details such as overall market size, top players in the industry, top products, important regions, new developments etc., which is validated using primary research to remove deviations and arrive at a data with high precision.  This is done by interviewing many industry specialists and subject matter experts, and also the data extracted from company websites, white papers, financial reports etc. All the information gathered is then integrated by Future Market Insights analysts to arrive at final data points pertaining to the global orthobiologics market. The market statistics are presented in a systematic and organised manner with diagrams, graphs etc., which helps the readers grasp the key outcomes at just a single glance. Moreover, a 24x7 analyst support is extended to our clients should the need be.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

Our Clients


See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology